Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Evoq Remedies Ltd has informed BSE that its Board of Directors meeting, originally scheduled for 27th May 2026, has been rescheduled to 30th May 2026 at 4:00 PM at the company's registered office in Ahmedabad. The meeting agenda includes consideration and approval of the Audited Financial Results for the half year and full year ended 31st March 2026, along with the Auditor's Report. The meeting may also take up any other business with the Chairperson's permission. This is a routine regulatory intimation under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The rescheduling is procedural in nature and does not indicate any adverse development. Investors should note that the financial results for FY2026 will now be considered on 30th May 2026.